Home » Topics » Conferences

Conferences
RSS

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

April 9, 1998

Novel topoisomerase I inhibitor discovered at Kaken

April 8, 1998

Symphar antineoplastic agent induces apoptosis and reverses MDR

April 8, 1998

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

April 8, 1998

Heparinase I pharmacokinetics evaluated in healthy volunteers

April 8, 1998

Ro-25-3036 improves dosing frequency of IFN in hepatitis patients

April 8, 1998

Factor Xa inhibitor selected for clinical trials at Berlex Biosciences

April 8, 1998

New factor Xa inhibitors designed at DuPont Merck

April 8, 1998

HBOC-201 reduces need for blood transfusions in surgery

April 8, 1998

Novel PDE IV inhibitors in the pipeline at Jouveinal/Parke-Davis

April 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.